

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ribosomal small subunit assembly (GO:0000028) | 5.05755319 |
| 2 | proteasome assembly (GO:0043248) | 5.00188992 |
| 3 | negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051436) | 4.77237537 |
| 4 | formation of translation preinitiation complex (GO:0001731) | 4.56547315 |
| 5 | positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051437) | 4.51802829 |
| 6 | maturation of SSU-rRNA (GO:0030490) | 4.48446034 |
| 7 | viral transcription (GO:0019083) | 4.43452611 |
| 8 | regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051439) | 4.41750440 |
| 9 | anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0 | 4.39490557 |
| 10 | translational termination (GO:0006415) | 4.36791181 |
| 11 | mitochondrial electron transport, NADH to ubiquinone (GO:0006120) | 4.36689258 |
| 12 | negative regulation of ligase activity (GO:0051352) | 4.32696182 |
| 13 | negative regulation of ubiquitin-protein transferase activity (GO:0051444) | 4.32696182 |
| 14 | respiratory electron transport chain (GO:0022904) | 4.31753007 |
| 15 | chaperone-mediated protein transport (GO:0072321) | 4.27673164 |
| 16 | DNA strand elongation involved in DNA replication (GO:0006271) | 4.27180359 |
| 17 | ribosomal large subunit biogenesis (GO:0042273) | 4.25679714 |
| 18 | electron transport chain (GO:0022900) | 4.20340714 |
| 19 | rRNA modification (GO:0000154) | 4.17737712 |
| 20 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO: | 4.13736932 |
| 21 | oxidative phosphorylation (GO:0006119) | 4.06455181 |
| 22 | ribosomal small subunit biogenesis (GO:0042274) | 4.05898288 |
| 23 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:00 | 4.04751803 |
| 24 | regulation of mitochondrial translation (GO:0070129) | 4.03445357 |
| 25 | antigen processing and presentation of exogenous peptide antigen via MHC class I (GO:0042590) | 4.03082912 |
| 26 | DNA strand elongation (GO:0022616) | 4.02685470 |
| 27 | establishment of protein localization to mitochondrial membrane (GO:0090151) | 4.02461132 |
| 28 | translational elongation (GO:0006414) | 4.02146711 |
| 29 | translational initiation (GO:0006413) | 4.01324796 |
| 30 | purine nucleobase biosynthetic process (GO:0009113) | 4.00604441 |
| 31 | regulation of cellular amino acid metabolic process (GO:0006521) | 3.98955656 |
| 32 | telomere maintenance via semi-conservative replication (GO:0032201) | 3.96735369 |
| 33 | establishment of integrated proviral latency (GO:0075713) | 3.95604798 |
| 34 | signal transduction involved in mitotic G1 DNA damage checkpoint (GO:0072431) | 3.95512606 |
| 35 | intracellular signal transduction involved in G1 DNA damage checkpoint (GO:1902400) | 3.95512606 |
| 36 | SRP-dependent cotranslational protein targeting to membrane (GO:0006614) | 3.95231578 |
| 37 | nucleobase biosynthetic process (GO:0046112) | 3.95044415 |
| 38 | signal transduction involved in mitotic cell cycle checkpoint (GO:0072413) | 3.91869896 |
| 39 | signal transduction involved in mitotic DNA integrity checkpoint (GO:1902403) | 3.91869896 |
| 40 | signal transduction involved in mitotic DNA damage checkpoint (GO:1902402) | 3.91869896 |
| 41 | signal transduction involved in DNA damage checkpoint (GO:0072422) | 3.88177554 |
| 42 | signal transduction involved in DNA integrity checkpoint (GO:0072401) | 3.88177554 |
| 43 | * positive regulation of ubiquitin-protein transferase activity (GO:0051443) | 3.87764902 |
| 44 | cotranslational protein targeting to membrane (GO:0006613) | 3.87496718 |
| 45 | protein targeting to ER (GO:0045047) | 3.85650891 |
| 46 | signal transduction involved in cell cycle checkpoint (GO:0072395) | 3.83995492 |
| 47 | protein targeting to mitochondrion (GO:0006626) | 3.82185878 |
| 48 | ribosome assembly (GO:0042255) | 3.75525438 |
| 49 | DNA replication checkpoint (GO:0000076) | 3.73119087 |
| 50 | * positive regulation of ligase activity (GO:0051351) | 3.69861554 |
| 51 | establishment of protein localization to endoplasmic reticulum (GO:0072599) | 3.64243735 |
| 52 | protein localization to endoplasmic reticulum (GO:0070972) | 3.63973161 |
| 53 | telomere maintenance via recombination (GO:0000722) | 3.62054427 |
| 54 | cullin deneddylation (GO:0010388) | 3.59008393 |
| 55 | translation (GO:0006412) | 3.56441292 |
| 56 | ribonucleoprotein complex biogenesis (GO:0022613) | 3.56146456 |
| 57 | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay (GO:0000184) | 3.55182850 |
| 58 | viral life cycle (GO:0019058) | 3.52345715 |
| 59 | rRNA methylation (GO:0031167) | 3.51593509 |
| 60 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 3.49236816 |
| 61 | cellular protein complex disassembly (GO:0043624) | 3.48926941 |
| 62 | spliceosomal snRNP assembly (GO:0000387) | 3.47469434 |
| 63 | protein complex biogenesis (GO:0070271) | 3.47182566 |
| 64 | mitochondrial respiratory chain complex assembly (GO:0033108) | 3.45678143 |
| 65 | DNA replication initiation (GO:0006270) | 3.44660022 |
| 66 | CENP-A containing nucleosome assembly (GO:0034080) | 3.43395207 |
| 67 | establishment of protein localization to mitochondrion (GO:0072655) | 3.43354982 |
| 68 | maturation of 5.8S rRNA (GO:0000460) | 3.42805541 |
| 69 | DNA unwinding involved in DNA replication (GO:0006268) | 3.41377922 |
| 70 | protein localization to mitochondrion (GO:0070585) | 3.41051162 |
| 71 | * regulation of ubiquitin-protein transferase activity (GO:0051438) | 3.40792894 |
| 72 | mitochondrial respiratory chain complex I assembly (GO:0032981) | 3.39848556 |
| 73 | NADH dehydrogenase complex assembly (GO:0010257) | 3.39848556 |
| 74 | mitochondrial respiratory chain complex I biogenesis (GO:0097031) | 3.39848556 |
| 75 | mitotic recombination (GO:0006312) | 3.38921567 |
| 76 | G1/S transition of mitotic cell cycle (GO:0000082) | 3.38685518 |
| 77 | cell cycle G1/S phase transition (GO:0044843) | 3.38685518 |
| 78 | mitotic metaphase plate congression (GO:0007080) | 3.35311181 |
| 79 | positive regulation of cell cycle arrest (GO:0071158) | 3.34659502 |
| 80 | protein deneddylation (GO:0000338) | 3.31764158 |
| 81 | chromatin remodeling at centromere (GO:0031055) | 3.31534629 |
| 82 | * regulation of ligase activity (GO:0051340) | 3.27854438 |
| 83 | protein neddylation (GO:0045116) | 3.27327656 |
| 84 | antigen processing and presentation of peptide antigen via MHC class I (GO:0002474) | 3.26961446 |
| 85 | L-methionine biosynthetic process from methylthioadenosine (GO:0019509) | 3.26934430 |
| 86 | regulation of cellular amine metabolic process (GO:0033238) | 3.26436830 |
| 87 | DNA deamination (GO:0045006) | 3.24640447 |
| 88 | termination of RNA polymerase III transcription (GO:0006386) | 3.22989231 |
| 89 | transcription elongation from RNA polymerase III promoter (GO:0006385) | 3.22989231 |
| 90 | exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay | 3.20487160 |
| 91 | protein localization to kinetochore (GO:0034501) | 3.20179670 |
| 92 | 7-methylguanosine mRNA capping (GO:0006370) | 3.19467221 |
| 93 | energy coupled proton transport, down electrochemical gradient (GO:0015985) | 3.19184854 |
| 94 | ATP synthesis coupled proton transport (GO:0015986) | 3.19184854 |
| 95 | rRNA processing (GO:0006364) | 3.18117981 |
| 96 | DNA damage response, signal transduction by p53 class mediator (GO:0030330) | 3.18048890 |
| 97 | ribosome biogenesis (GO:0042254) | 3.17174108 |
| 98 | DNA catabolic process, exonucleolytic (GO:0000738) | 3.17155880 |
| 99 | nuclear-transcribed mRNA catabolic process, exonucleolytic (GO:0000291) | 3.14774366 |
| 100 | nucleobase-containing small molecule interconversion (GO:0015949) | 3.14433868 |
| 101 | IMP biosynthetic process (GO:0006188) | 3.13627889 |
| 102 | tRNA aminoacylation for protein translation (GO:0006418) | 3.12404997 |
| 103 | RNA capping (GO:0036260) | 3.12114336 |
| 104 | 7-methylguanosine RNA capping (GO:0009452) | 3.12114336 |
| 105 | folic acid-containing compound biosynthetic process (GO:0009396) | 3.11346579 |
| 106 | establishment of viral latency (GO:0019043) | 3.11182637 |
| 107 | spliceosomal complex assembly (GO:0000245) | 3.10932159 |
| 108 | mitotic sister chromatid segregation (GO:0000070) | 3.10863423 |
| 109 | tRNA aminoacylation (GO:0043039) | 3.09600643 |
| 110 | amino acid activation (GO:0043038) | 3.09600643 |
| 111 | pseudouridine synthesis (GO:0001522) | 3.09152270 |
| 112 | nucleotide-excision repair, DNA gap filling (GO:0006297) | 3.08685988 |
| 113 | ATP biosynthetic process (GO:0006754) | 3.08653380 |
| 114 | protein complex disassembly (GO:0043241) | 3.08222005 |
| 115 | negative regulation of protein modification by small protein conjugation or removal (GO:1903321) | 3.07876908 |
| 116 | purine ribonucleoside monophosphate biosynthetic process (GO:0009168) | 3.07642856 |
| 117 | purine nucleoside monophosphate biosynthetic process (GO:0009127) | 3.07642856 |
| 118 | rRNA metabolic process (GO:0016072) | 3.07144997 |
| 119 | respiratory chain complex IV assembly (GO:0008535) | 3.05628658 |
| 120 | transcription-coupled nucleotide-excision repair (GO:0006283) | 3.05390985 |
| 121 | viral mRNA export from host cell nucleus (GO:0046784) | 3.04213122 |
| 122 | deoxyribonucleoside monophosphate metabolic process (GO:0009162) | 3.03493023 |
| 123 | mitotic nuclear envelope disassembly (GO:0007077) | 3.01969396 |
| 124 | telomere maintenance via telomere lengthening (GO:0010833) | 3.00007117 |
| 125 | macromolecular complex disassembly (GO:0032984) | 2.99019105 |
| 126 | DNA replication-independent nucleosome organization (GO:0034724) | 2.95120027 |
| 127 | DNA replication-independent nucleosome assembly (GO:0006336) | 2.95120027 |
| 128 | kinetochore organization (GO:0051383) | 2.92414315 |
| 129 | signal transduction in response to DNA damage (GO:0042770) | 2.87640933 |
| 130 | cellular component biogenesis (GO:0044085) | 2.87614372 |
| 131 | regulation of transcription involved in G1/S transition of mitotic cell cycle (GO:0000083) | 2.87127073 |
| 132 | regulation of protein heterodimerization activity (GO:0043497) | 2.86012529 |
| 133 | negative regulation of protein ubiquitination (GO:0031397) | 2.85784812 |
| 134 | establishment of chromosome localization (GO:0051303) | 2.85616419 |
| 135 | regulation of cell cycle arrest (GO:0071156) | 2.84944380 |
| 136 | DNA replication-dependent nucleosome assembly (GO:0006335) | 2.83891750 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | E2F7_22180533_ChIP-Seq_HELA_Human | 6.40450154 |
| 2 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 4.25288907 |
| 3 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 4.08169186 |
| 4 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 3.85966078 |
| 5 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 3.53558064 |
| 6 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 3.53216738 |
| 7 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 3.38822504 |
| 8 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 3.22269060 |
| 9 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 3.11611422 |
| 10 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 2.99365199 |
| 11 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 2.88705214 |
| 12 | * MYC_18358816_ChIP-ChIP_MESCs_Mouse | 2.84764281 |
| 13 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 2.82789923 |
| 14 | * MYC_19030024_ChIP-ChIP_MESCs_Mouse | 2.68294276 |
| 15 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 2.66883126 |
| 16 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 2.63206378 |
| 17 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 2.54960423 |
| 18 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 2.46577395 |
| 19 | * XRN2_22483619_ChIP-Seq_HELA_Human | 2.45757299 |
| 20 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 2.45038499 |
| 21 | * VDR_23849224_ChIP-Seq_CD4+_Human | 2.34704502 |
| 22 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 2.31999568 |
| 23 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 2.31671327 |
| 24 | DCP1A_22483619_ChIP-Seq_HELA_Human | 2.25018377 |
| 25 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 2.12953314 |
| 26 | * E2F1_18555785_ChIP-Seq_MESCs_Mouse | 2.12557030 |
| 27 | ELK1_19687146_ChIP-ChIP_HELA_Human | 1.99958033 |
| 28 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.99350512 |
| 29 | GABP_19822575_ChIP-Seq_HepG2_Human | 1.97865897 |
| 30 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 1.92710834 |
| 31 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 1.90463378 |
| 32 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.88657717 |
| 33 | TTF2_22483619_ChIP-Seq_HELA_Human | 1.87726183 |
| 34 | AR_21909140_ChIP-Seq_LNCAP_Human | 1.85909428 |
| 35 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.80446349 |
| 36 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 1.77557141 |
| 37 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.69218547 |
| 38 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.66968626 |
| 39 | POU5F1_18555785_ChIP-Seq_MESCs_Mouse | 1.66936512 |
| 40 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 1.65396454 |
| 41 | * MYBL2_22936984_ChIP-ChIP_MESCs_Mouse | 1.65359993 |
| 42 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.64805619 |
| 43 | * HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.62786257 |
| 44 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.60994546 |
| 45 | MYCN_18555785_ChIP-Seq_MESCs_Mouse | 1.60528494 |
| 46 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.60178441 |
| 47 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 1.54424745 |
| 48 | * ZFX_18555785_ChIP-Seq_MESCs_Mouse | 1.53328776 |
| 49 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 1.49006625 |
| 50 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.48558184 |
| 51 | * ZFP42_18358816_ChIP-ChIP_MESCs_Mouse | 1.44382339 |
| 52 | NANOG_18555785_ChIP-Seq_MESCs_Mouse | 1.44123798 |
| 53 | KDM5A_27292631_Chip-Seq_BREAST_Human | 1.42387148 |
| 54 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.41683511 |
| 55 | CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 1.40512853 |
| 56 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.39383496 |
| 57 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.38790641 |
| 58 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.35565539 |
| 59 | * YY1_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.33787988 |
| 60 | ELK1_22589737_ChIP-Seq_MCF10A_Human | 1.32559086 |
| 61 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.27476084 |
| 62 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.26223130 |
| 63 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.25900324 |
| 64 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.25579415 |
| 65 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.24351517 |
| 66 | CUX1_19635798_ChIP-ChIP_MULTIPLE_HUMAN_CANCER_TYPES_Human | 1.20453569 |
| 67 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.20222357 |
| 68 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.15998196 |
| 69 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 1.15137171 |
| 70 | PADI4_21655091_ChIP-ChIP_MCF-7_Human | 1.13605975 |
| 71 | E2F4_21247883_ChIP-Seq_LYMPHOBLASTOID_Human | 1.13251432 |
| 72 | MYC_22102868_ChIP-Seq_BL_Human | 1.13072175 |
| 73 | KLF4_18555785_ChIP-Seq_MESCs_Mouse | 1.12945067 |
| 74 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 1.11717886 |
| 75 | PRDM5_23873026_ChIP-Seq_MEFs_Mouse | 1.06788612 |
| 76 | KLF4_19030024_ChIP-ChIP_MESCs_Mouse | 1.05056343 |
| 77 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.04647880 |
| 78 | POU5F1_18358816_ChIP-ChIP_MESCs_Mouse | 1.04489866 |
| 79 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.04232961 |
| 80 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.04125275 |
| 81 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.03026621 |
| 82 | KDM5B_21448134_ChIP-Seq_MESCs_Mouse | 1.02990346 |
| 83 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.02432672 |
| 84 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 1.02288078 |
| 85 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 1.00705910 |
| 86 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 0.98800820 |
| 87 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 0.97810942 |
| 88 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 0.97411772 |
| 89 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 0.97231235 |
| 90 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 0.96960669 |
| 91 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 0.94981325 |
| 92 | OCT4_18692474_ChIP-Seq_MEFs_Mouse | 0.94086201 |
| 93 | ASH2L_23239880_ChIP-Seq_MESCs_Mouse | 0.93724462 |
| 94 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 0.91461876 |
| 95 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 0.91335623 |
| 96 | MYC_18940864_ChIP-ChIP_HL60_Human | 0.90177720 |
| 97 | CREM_20920259_ChIP-Seq_GC1-SPG_Mouse | 0.89120427 |
| 98 | * CNOT3_19339689_ChIP-ChIP_MESCs_Mouse | 0.88578489 |
| 99 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 0.88249995 |
| 100 | SOX17_20123909_ChIP-Seq_XEN_Mouse | 0.87305538 |
| 101 | * STAT3_1855785_ChIP-Seq_MESCs_Mouse | 0.87257845 |
| 102 | VDR_21846776_ChIP-Seq_THP-1_Human | 0.85405960 |
| 103 | SIN3A_21632747_ChIP-Seq_MESCs_Mouse | 0.85222702 |
| 104 | SOX2_18692474_ChIP-Seq_MEFs_Mouse | 0.83898892 |
| 105 | ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 0.83537393 |
| 106 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 0.83422708 |
| 107 | DMRT1_21621532_ChIP-ChIP_FETAL_Ovary | 0.79931030 |
| 108 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.77883464 |
| 109 | CREB1_23762244_ChIP-Seq_HIPPOCAMPUS_Rat | 0.76643462 |
| 110 | TBX5_21415370_ChIP-Seq_HL-1_Mouse | 0.75334010 |
| 111 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 0.75253468 |
| 112 | * FLI1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.74721706 |
| 113 | * NCOR1_26117541_ChIP-Seq_K562_Human | 0.74068834 |
| 114 | NANOG_16153702_ChIP-ChIP_HESCs_Human | 0.72080057 |
| 115 | SOX2_18555785_ChIP-Seq_MESCs_Mouse | 0.71013179 |
| 116 | CTCF_18555785_ChIP-Seq_MESCs_Mouse | 0.70512326 |
| 117 | * ELF5_23300383_ChIP-Seq_T47D_Human | 0.68783736 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003693_abnormal_embryo_hatching | 4.33736031 |
| 2 | MP0004957_abnormal_blastocyst_morpholog | 4.23677552 |
| 3 | MP0003111_abnormal_nucleus_morphology | 3.54649873 |
| 4 | MP0003077_abnormal_cell_cycle | 3.50822987 |
| 5 | MP0010094_abnormal_chromosome_stability | 3.50020011 |
| 6 | MP0009697_abnormal_copulation | 3.37844950 |
| 7 | MP0008057_abnormal_DNA_replication | 2.84193389 |
| 8 | MP0003123_paternal_imprinting | 2.73782035 |
| 9 | MP0008007_abnormal_cellular_replicative | 2.72075366 |
| 10 | MP0004147_increased_porphyrin_level | 2.71945357 |
| 11 | MP0008932_abnormal_embryonic_tissue | 2.64804504 |
| 12 | MP0003186_abnormal_redox_activity | 2.21694040 |
| 13 | MP0008058_abnormal_DNA_repair | 2.18666144 |
| 14 | MP0010352_gastrointestinal_tract_polyps | 2.12473219 |
| 15 | MP0001730_embryonic_growth_arrest | 2.10635640 |
| 16 | MP0002396_abnormal_hematopoietic_system | 2.10268454 |
| 17 | MP0009333_abnormal_splenocyte_physiolog | 1.95575523 |
| 18 | MP0000350_abnormal_cell_proliferation | 1.95332567 |
| 19 | MP0003941_abnormal_skin_development | 1.77439646 |
| 20 | MP0001835_abnormal_antigen_presentation | 1.76515947 |
| 21 | MP0010030_abnormal_orbit_morphology | 1.74336800 |
| 22 | MP0008995_early_reproductive_senescence | 1.73315679 |
| 23 | MP0000490_abnormal_crypts_of | 1.67747926 |
| 24 | MP0002148_abnormal_hypersensitivity_rea | 1.64930070 |
| 25 | MP0003806_abnormal_nucleotide_metabolis | 1.61656433 |
| 26 | MP0003436_decreased_susceptibility_to | 1.56426428 |
| 27 | MP0001697_abnormal_embryo_size | 1.54446228 |
| 28 | MP0005058_abnormal_lysosome_morphology | 1.50174276 |
| 29 | MP0009785_altered_susceptibility_to | 1.48281580 |
| 30 | MP0006054_spinal_hemorrhage | 1.44960830 |
| 31 | MP0000313_abnormal_cell_death | 1.42947283 |
| 32 | MP0000858_altered_metastatic_potential | 1.42772161 |
| 33 | MP0003315_abnormal_perineum_morphology | 1.38553130 |
| 34 | * MP0002080_prenatal_lethality | 1.36918618 |
| 35 | MP0006292_abnormal_olfactory_placode | 1.35352533 |
| 36 | MP0000678_abnormal_parathyroid_gland | 1.32835096 |
| 37 | MP0004808_abnormal_hematopoietic_stem | 1.31189323 |
| 38 | MP0001529_abnormal_vocalization | 1.30640832 |
| 39 | MP0010307_abnormal_tumor_latency | 1.29745737 |
| 40 | MP0003221_abnormal_cardiomyocyte_apopto | 1.28759399 |
| 41 | MP0003567_abnormal_fetal_cardiomyocyte | 1.28396500 |
| 42 | MP0003786_premature_aging | 1.27787678 |
| 43 | MP0003705_abnormal_hypodermis_morpholog | 1.25810101 |
| 44 | MP0003718_maternal_effect | 1.24959666 |
| 45 | MP0005000_abnormal_immune_tolerance | 1.24816609 |
| 46 | MP0001764_abnormal_homeostasis | 1.24470960 |
| 47 | MP0001853_heart_inflammation | 1.23681270 |
| 48 | MP0009379_abnormal_foot_pigmentation | 1.23667519 |
| 49 | MP0002398_abnormal_bone_marrow | 1.23561458 |
| 50 | * MP0005380_embryogenesis_phenotype | 1.23409993 |
| 51 | * MP0001672_abnormal_embryogenesis/_devel | 1.23409993 |
| 52 | MP0006036_abnormal_mitochondrial_physio | 1.23169221 |
| 53 | * MP0003984_embryonic_growth_retardation | 1.23131276 |
| 54 | MP0001545_abnormal_hematopoietic_system | 1.22776885 |
| 55 | MP0005397_hematopoietic_system_phenotyp | 1.22776885 |
| 56 | MP0000750_abnormal_muscle_regeneration | 1.22202725 |
| 57 | MP0000358_abnormal_cell_content/ | 1.21268897 |
| 58 | * MP0002088_abnormal_embryonic_growth/wei | 1.19089433 |
| 59 | MP0002452_abnormal_antigen_presenting | 1.18505482 |
| 60 | MP0000343_altered_response_to | 1.18485109 |
| 61 | MP0005025_abnormal_response_to | 1.17897907 |
| 62 | MP0002019_abnormal_tumor_incidence | 1.17407881 |
| 63 | MP0003448_altered_tumor_morphology | 1.16515045 |
| 64 | MP0002419_abnormal_innate_immunity | 1.14610479 |
| 65 | MP0005410_abnormal_fertilization | 1.14304838 |
| 66 | MP0005671_abnormal_response_to | 1.13715930 |
| 67 | MP0002722_abnormal_immune_system | 1.13604515 |
| 68 | MP0001929_abnormal_gametogenesis | 1.11851686 |
| 69 | MP0002163_abnormal_gland_morphology | 1.11548348 |
| 70 | MP0009053_abnormal_anal_canal | 1.11397943 |
| 71 | MP0003950_abnormal_plasma_membrane | 1.10061354 |
| 72 | MP0004197_abnormal_fetal_growth/weight/ | 1.09653417 |
| 73 | MP0002429_abnormal_blood_cell | 1.08802226 |
| 74 | MP0001819_abnormal_immune_cell | 1.08382301 |
| 75 | MP0005636_abnormal_mineral_homeostasis | 1.08301093 |
| 76 | MP0002210_abnormal_sex_determination | 1.07395626 |
| 77 | MP0002420_abnormal_adaptive_immunity | 1.06556353 |
| 78 | MP0000689_abnormal_spleen_morphology | 1.05541482 |
| 79 | MP0008789_abnormal_olfactory_epithelium | 1.04644249 |
| 80 | MP0001661_extended_life_span | 1.04542469 |
| 81 | MP0001542_abnormal_bone_strength | 1.03213660 |
| 82 | MP0002405_respiratory_system_inflammati | 1.02487382 |
| 83 | MP0001881_abnormal_mammary_gland | 1.00709699 |
| 84 | MP0006082_CNS_inflammation | 1.00504360 |
| 85 | MP0000537_abnormal_urethra_morphology | 1.00457706 |
| 86 | MP0000716_abnormal_immune_system | 1.00416180 |
| 87 | MP0000703_abnormal_thymus_morphology | 0.98845043 |
| 88 | MP0002723_abnormal_immune_serum | 0.96453362 |
| 89 | MP0002085_abnormal_embryonic_tissue | 0.96444520 |
| 90 | MP0003303_peritoneal_inflammation | 0.95612305 |
| 91 | MP0005084_abnormal_gallbladder_morpholo | 0.94666599 |
| 92 | MP0006035_abnormal_mitochondrial_morpho | 0.92582073 |
| 93 | * MP0002086_abnormal_extraembryonic_tissu | 0.92041481 |
| 94 | MP0001905_abnormal_dopamine_level | 0.91702653 |
| 95 | MP0001727_abnormal_embryo_implantation | 0.90537763 |
| 96 | MP0001800_abnormal_humoral_immune | 0.90304000 |
| 97 | MP0002160_abnormal_reproductive_system | 0.84454361 |
| 98 | MP0005023_abnormal_wound_healing | 0.84412124 |
| 99 | MP0000685_abnormal_immune_system | 0.83167871 |
| 100 | MP0002736_abnormal_nociception_after | 0.82247725 |
| 101 | MP0003656_abnormal_erythrocyte_physiolo | 0.80730977 |
| 102 | MP0004233_abnormal_muscle_weight | 0.80721117 |
| 103 | MP0005395_other_phenotype | 0.80379523 |
| 104 | MP0001145_abnormal_male_reproductive | 0.79830749 |
| 105 | MP0001533_abnormal_skeleton_physiology | 0.79628420 |
| 106 | MP0000653_abnormal_sex_gland | 0.78681945 |
| 107 | MP0005332_abnormal_amino_acid | 0.78317295 |
| 108 | MP0008438_abnormal_cutaneous_collagen | 0.78257969 |
| 109 | MP0001293_anophthalmia | 0.77851994 |
| 110 | MP0002938_white_spotting | 0.77118247 |
| 111 | MP0005384_cellular_phenotype | 0.75949493 |
| 112 | MP0005330_cardiomyopathy | 0.75894477 |
| 113 | MP0009672_abnormal_birth_weight | 0.75384380 |
| 114 | MP0005501_abnormal_skin_physiology | 0.74389705 |
| 115 | MP0002277_abnormal_respiratory_mucosa | 0.73701940 |
| 116 | MP0002132_abnormal_respiratory_system | 0.72727559 |
| 117 | MP0005408_hypopigmentation | 0.72283629 |
| 118 | MP0000733_abnormal_muscle_development | 0.71990368 |
| 119 | MP0006072_abnormal_retinal_apoptosis | 0.71597626 |
| 120 | MP0000372_irregular_coat_pigmentation | 0.70534253 |
| 121 | MP0008877_abnormal_DNA_methylation | 0.70506027 |
| 122 | MP0001845_abnormal_inflammatory_respons | 0.69335985 |
| 123 | MP0000749_muscle_degeneration | 0.69211788 |
| 124 | MP0004084_abnormal_cardiac_muscle | 0.69071119 |
| 125 | MP0005083_abnormal_biliary_tract | 0.68507782 |
| 126 | MP0002084_abnormal_developmental_patter | 0.68337287 |
| 127 | MP0003763_abnormal_thymus_physiology | 0.68172426 |
| 128 | MP0010155_abnormal_intestine_physiology | 0.67340918 |
| 129 | MP0001790_abnormal_immune_system | 0.66214524 |
| 130 | MP0005387_immune_system_phenotype | 0.66214524 |
| 131 | MP0008872_abnormal_physiological_respon | 0.64579222 |
| 132 | MP0003121_genomic_imprinting | 0.64539893 |
| 133 | MP0008873_increased_physiological_sensi | 0.63518037 |
| 134 | MP0004215_abnormal_myocardial_fiber | 0.61627483 |
| 135 | MP0001119_abnormal_female_reproductive | 0.61309129 |
| 136 | MP0008875_abnormal_xenobiotic_pharmacok | 0.61180267 |
| 137 | MP0002837_dystrophic_cardiac_calcinosis | 0.56893992 |
| 138 | MP0002102_abnormal_ear_morphology | 0.56057534 |
| 139 | MP0002161_abnormal_fertility/fecundity | 0.55291848 |
| 140 | MP0005499_abnormal_olfactory_system | 0.54960387 |
| 141 | MP0005394_taste/olfaction_phenotype | 0.54960387 |
| 142 | MP0002269_muscular_atrophy | 0.53885969 |
| 143 | MP0003698_abnormal_male_reproductive | 0.53531179 |
| 144 | MP0002090_abnormal_vision | 0.52960907 |
| 145 | MP0005464_abnormal_platelet_physiology | 0.52876884 |
| 146 | MP0004019_abnormal_vitamin_homeostasis | 0.52287758 |
| 147 | MP0005319_abnormal_enzyme/_coenzyme | 0.51958363 |
| 148 | MP0002111_abnormal_tail_morphology | 0.50773168 |
| 149 | MP0005389_reproductive_system_phenotype | 0.49131605 |
| 150 | MP0002095_abnormal_skin_pigmentation | 0.48502456 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Abnormality of cells of the erythroid lineage (HP:0012130) | 4.81185044 |
| 2 | Abnormal number of erythroid precursors (HP:0012131) | 4.43865574 |
| 3 | Reticulocytopenia (HP:0001896) | 4.23958790 |
| 4 | Abnormality of the anterior horn cell (HP:0006802) | 3.95763924 |
| 5 | Degeneration of anterior horn cells (HP:0002398) | 3.95763924 |
| 6 | Cerebral edema (HP:0002181) | 3.74969942 |
| 7 | Multiple enchondromatosis (HP:0005701) | 3.74561306 |
| 8 | Cerebral hypomyelination (HP:0006808) | 3.62749180 |
| 9 | Abnormal gallbladder physiology (HP:0012438) | 3.62578744 |
| 10 | Cholecystitis (HP:0001082) | 3.62578744 |
| 11 | Macrocytic anemia (HP:0001972) | 3.44029328 |
| 12 | Birth length less than 3rd percentile (HP:0003561) | 3.34922466 |
| 13 | Type I transferrin isoform profile (HP:0003642) | 3.25345140 |
| 14 | Abnormality of glycolysis (HP:0004366) | 3.22041346 |
| 15 | Increased serum pyruvate (HP:0003542) | 3.22041346 |
| 16 | Poor head control (HP:0002421) | 3.21119369 |
| 17 | Lactic acidosis (HP:0003128) | 3.20223044 |
| 18 | Truncus arteriosus (HP:0001660) | 3.19210665 |
| 19 | Increased intramyocellular lipid droplets (HP:0012240) | 3.16259219 |
| 20 | Acute necrotizing encephalopathy (HP:0006965) | 3.09108479 |
| 21 | Rough bone trabeculation (HP:0100670) | 3.06469771 |
| 22 | Breast hypoplasia (HP:0003187) | 3.04513325 |
| 23 | Mitochondrial inheritance (HP:0001427) | 3.04509778 |
| 24 | Carpal bone hypoplasia (HP:0001498) | 3.00528409 |
| 25 | Pallor (HP:0000980) | 2.90924704 |
| 26 | Agnosia (HP:0010524) | 2.89804914 |
| 27 | Trismus (HP:0000211) | 2.85240971 |
| 28 | Oral leukoplakia (HP:0002745) | 2.84207114 |
| 29 | Hyperthyroidism (HP:0000836) | 2.81394368 |
| 30 | Increased CSF lactate (HP:0002490) | 2.79375491 |
| 31 | Recurrent abscess formation (HP:0002722) | 2.78155871 |
| 32 | Increased hepatocellular lipid droplets (HP:0006565) | 2.77989151 |
| 33 | Abnormal mitochondria in muscle tissue (HP:0008316) | 2.75599856 |
| 34 | Hepatocellular necrosis (HP:0001404) | 2.75569238 |
| 35 | Colon cancer (HP:0003003) | 2.73690695 |
| 36 | Exertional dyspnea (HP:0002875) | 2.72897875 |
| 37 | Patellar aplasia (HP:0006443) | 2.71037802 |
| 38 | Increased muscle lipid content (HP:0009058) | 2.68869200 |
| 39 | Aplasia/Hypoplasia of the patella (HP:0006498) | 2.67507963 |
| 40 | Leukodystrophy (HP:0002415) | 2.65163588 |
| 41 | Decreased activity of cytochrome C oxidase in muscle tissue (HP:0003688) | 2.62561172 |
| 42 | Abnormality of methionine metabolism (HP:0010901) | 2.58638557 |
| 43 | Abnormal isoelectric focusing of serum transferrin (HP:0003160) | 2.58106895 |
| 44 | Abnormal protein N-linked glycosylation (HP:0012347) | 2.58106895 |
| 45 | Abnormal protein glycosylation (HP:0012346) | 2.58106895 |
| 46 | Abnormal glycosylation (HP:0012345) | 2.58106895 |
| 47 | Hepatic necrosis (HP:0002605) | 2.55716905 |
| 48 | Lipid accumulation in hepatocytes (HP:0006561) | 2.48001165 |
| 49 | Progressive macrocephaly (HP:0004481) | 2.46319766 |
| 50 | Pancytopenia (HP:0001876) | 2.45652748 |
| 51 | Lethargy (HP:0001254) | 2.41147075 |
| 52 | Chromosomal breakage induced by crosslinking agents (HP:0003221) | 2.39547658 |
| 53 | Acute encephalopathy (HP:0006846) | 2.37717924 |
| 54 | Abnormality of the umbilical cord (HP:0010881) | 2.34873202 |
| 55 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 2.34252122 |
| 56 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 2.34252122 |
| 57 | Chromsome breakage (HP:0040012) | 2.32911085 |
| 58 | Hypertensive crisis (HP:0100735) | 2.32821666 |
| 59 | Respiratory failure (HP:0002878) | 2.32640786 |
| 60 | Abnormal trabecular bone morphology (HP:0100671) | 2.32035780 |
| 61 | Nausea (HP:0002018) | 2.31189541 |
| 62 | Recurrent bacterial skin infections (HP:0005406) | 2.31112458 |
| 63 | Reduced antithrombin III activity (HP:0001976) | 2.30781430 |
| 64 | Increased serum lactate (HP:0002151) | 2.26701337 |
| 65 | Aplasia/Hypoplasia of the sacrum (HP:0008517) | 2.26134176 |
| 66 | Premature graying of hair (HP:0002216) | 2.24371211 |
| 67 | Abnormality of the heme biosynthetic pathway (HP:0010472) | 2.23692343 |
| 68 | Seborrheic dermatitis (HP:0001051) | 2.23664747 |
| 69 | Emotional lability (HP:0000712) | 2.23499484 |
| 70 | Exercise intolerance (HP:0003546) | 2.21927040 |
| 71 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 2.20662889 |
| 72 | Atrophy/Degeneration involving motor neurons (HP:0007373) | 2.17656752 |
| 73 | Cleft eyelid (HP:0000625) | 2.17227093 |
| 74 | Short middle phalanx of the 5th finger (HP:0004220) | 2.15966513 |
| 75 | Abnormality of the preputium (HP:0100587) | 2.15650490 |
| 76 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 2.15602607 |
| 77 | Abnormality of alanine metabolism (HP:0010916) | 2.15602607 |
| 78 | Hyperalaninemia (HP:0003348) | 2.15602607 |
| 79 | Aplastic anemia (HP:0001915) | 2.14324029 |
| 80 | Abnormality of homocysteine metabolism (HP:0010919) | 2.14322247 |
| 81 | Homocystinuria (HP:0002156) | 2.14322247 |
| 82 | Petechiae (HP:0000967) | 2.12956958 |
| 83 | Optic disc pallor (HP:0000543) | 2.12930781 |
| 84 | Palpitations (HP:0001962) | 2.11263466 |
| 85 | Muscle abnormality related to mitochondrial dysfunction (HP:0003800) | 2.09988637 |
| 86 | Neoplasm of the pancreas (HP:0002894) | 2.09808136 |
| 87 | Methylmalonic acidemia (HP:0002912) | 2.07598230 |
| 88 | Methylmalonic aciduria (HP:0012120) | 2.05703335 |
| 89 | Abnormality of reticulocytes (HP:0004312) | 2.04634964 |
| 90 | Abnormal hemoglobin (HP:0011902) | 2.02932803 |
| 91 | Secondary amenorrhea (HP:0000869) | 2.00812175 |
| 92 | Abnormality of the ileum (HP:0001549) | 2.00772866 |
| 93 | Personality changes (HP:0000751) | 1.99712238 |
| 94 | Congenital nonbullous ichthyosiform erythroderma (HP:0007479) | 1.99664785 |
| 95 | Nemaline bodies (HP:0003798) | 1.98772375 |
| 96 | Small intestinal stenosis (HP:0012848) | 1.98050564 |
| 97 | Duodenal stenosis (HP:0100867) | 1.98050564 |
| 98 | Postnatal microcephaly (HP:0005484) | 1.97557411 |
| 99 | Generalized aminoaciduria (HP:0002909) | 1.96311095 |
| 100 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 1.96052287 |
| 101 | Premature ovarian failure (HP:0008209) | 1.94881506 |
| 102 | Respiratory difficulties (HP:0002880) | 1.94795855 |
| 103 | Adenoma sebaceum (HP:0009720) | 1.92856657 |
| 104 | Angiofibromas (HP:0010615) | 1.92856657 |
| 105 | Hepatosplenomegaly (HP:0001433) | 1.92842358 |
| 106 | Atresia of the external auditory canal (HP:0000413) | 1.92384688 |
| 107 | Progressive muscle weakness (HP:0003323) | 1.92214498 |
| 108 | Abnormality of serum amino acid levels (HP:0003112) | 1.91877535 |
| 109 | Abnormality of the tricuspid valve (HP:0001702) | 1.91229999 |
| 110 | Abnormalities of placenta or umbilical cord (HP:0001194) | 1.90306124 |
| 111 | X-linked dominant inheritance (HP:0001423) | 1.89770899 |
| 112 | Thrombocytosis (HP:0001894) | 1.89389069 |
| 113 | Glossoptosis (HP:0000162) | 1.89376384 |
| 114 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 1.89190176 |
| 115 | Microretrognathia (HP:0000308) | 1.89025371 |
| 116 | Aplasia/Hypoplasia of the uvula (HP:0010293) | 1.88576334 |
| 117 | Eczematoid dermatitis (HP:0000976) | 1.86669127 |
| 118 | CNS demyelination (HP:0007305) | 1.86492588 |
| 119 | Selective tooth agenesis (HP:0001592) | 1.86258283 |
| 120 | Calcaneovalgus deformity (HP:0001848) | 1.86229091 |
| 121 | Redundant skin (HP:0001582) | 1.85518293 |
| 122 | Testicular atrophy (HP:0000029) | 1.85251311 |
| 123 | Abnormality of renal resorption (HP:0011038) | 1.84468180 |
| 124 | Horseshoe kidney (HP:0000085) | 1.81451225 |
| 125 | Abnormal lung lobation (HP:0002101) | 1.80998378 |
| 126 | Abnormality of macrophages (HP:0004311) | 1.80800145 |
| 127 | Congenital ichthyosiform erythroderma (HP:0007431) | 1.80750634 |
| 128 | Renal Fanconi syndrome (HP:0001994) | 1.80631235 |
| 129 | Mucosal telangiectasiae (HP:0100579) | 1.80450171 |
| 130 | Vertebral compression fractures (HP:0002953) | 1.79530728 |
| 131 | Aplasia/Hypoplasia involving the musculature (HP:0001460) | 1.77770908 |
| 132 | Meckel diverticulum (HP:0002245) | 1.77643251 |
| 133 | Abnormality of placental membranes (HP:0011409) | 1.76838297 |
| 134 | Amniotic constriction ring (HP:0009775) | 1.76838297 |
| 135 | Chronic obstructive pulmonary disease (HP:0006510) | 1.76452787 |
| 136 | Obstructive lung disease (HP:0006536) | 1.76452787 |
| 137 | Elevated erythrocyte sedimentation rate (HP:0003565) | 1.76352584 |
| 138 | Aplasia/Hypoplasia involving the carpal bones (HP:0006502) | 1.75204986 |
| 139 | Abnormality of the calcaneus (HP:0008364) | 1.74192629 |
| 140 | 3-Methylglutaconic aciduria (HP:0003535) | 1.74031573 |
| 141 | Microvesicular hepatic steatosis (HP:0001414) | 1.73694798 |
| 142 | 11 pairs of ribs (HP:0000878) | 1.73313153 |
| 143 | Basal ganglia calcification (HP:0002135) | 1.73194626 |
| 144 | Irregular epiphyses (HP:0010582) | 1.73034542 |
| 145 | Sparse eyelashes (HP:0000653) | 1.71281757 |
| 146 | CNS hypomyelination (HP:0003429) | 1.70420724 |
| 147 | Bone marrow hypocellularity (HP:0005528) | 1.70417104 |
| 148 | Deformed tarsal bones (HP:0008119) | 1.70308681 |
| 149 | Slender long bone (HP:0003100) | 1.70072778 |
| 150 | Vacuolated lymphocytes (HP:0001922) | 1.69896550 |
| 151 | Neoplasm of the adrenal gland (HP:0100631) | 1.68656675 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BUB1 | 5.18151119 |
| 2 | EIF2AK1 | 4.77914965 |
| 3 | VRK2 | 3.50045140 |
| 4 | WEE1 | 3.29459851 |
| 5 | PBK | 3.24595577 |
| 6 | NME2 | 3.09305518 |
| 7 | CDC7 | 2.59710654 |
| 8 | TESK2 | 2.46178625 |
| 9 | PIM2 | 2.44691834 |
| 10 | SRPK1 | 2.40042244 |
| 11 | BRSK2 | 2.17555892 |
| 12 | TLK1 | 2.14999669 |
| 13 | NEK1 | 2.09685552 |
| 14 | MAP3K12 | 2.07978647 |
| 15 | TESK1 | 2.04676676 |
| 16 | EIF2AK3 | 2.02814230 |
| 17 | LIMK1 | 2.01200398 |
| 18 | MKNK1 | 1.80266559 |
| 19 | PLK4 | 1.78792816 |
| 20 | PDK2 | 1.75401990 |
| 21 | TSSK6 | 1.68401224 |
| 22 | STK16 | 1.64863834 |
| 23 | BRSK1 | 1.60382582 |
| 24 | NEK9 | 1.59708101 |
| 25 | MST4 | 1.53597738 |
| 26 | LRRK2 | 1.52058830 |
| 27 | RPS6KA4 | 1.43408249 |
| 28 | VRK1 | 1.40438502 |
| 29 | PLK1 | 1.38458945 |
| 30 | ILK | 1.37066361 |
| 31 | TRIM28 | 1.30539111 |
| 32 | PLK3 | 1.30095314 |
| 33 | SCYL2 | 1.27083033 |
| 34 | PAK4 | 1.26001104 |
| 35 | NME1 | 1.21377893 |
| 36 | KDR | 1.19945588 |
| 37 | ABL2 | 1.17817117 |
| 38 | AURKB | 1.17645729 |
| 39 | AURKA | 1.17191172 |
| 40 | STK4 | 1.15128611 |
| 41 | BCKDK | 1.11687918 |
| 42 | MAP3K8 | 1.11198471 |
| 43 | ACVR1B | 1.05877304 |
| 44 | NEK2 | 1.04927756 |
| 45 | MKNK2 | 1.00122633 |
| 46 | CDK7 | 0.98551149 |
| 47 | DAPK1 | 0.96985541 |
| 48 | NUAK1 | 0.95838164 |
| 49 | RPS6KB2 | 0.95502806 |
| 50 | TTK | 0.93891987 |
| 51 | PAK1 | 0.93015741 |
| 52 | ERBB3 | 0.92298241 |
| 53 | DYRK3 | 0.92117807 |
| 54 | RAF1 | 0.91534899 |
| 55 | STK10 | 0.91365763 |
| 56 | CDK8 | 0.88311124 |
| 57 | BMPR2 | 0.87682881 |
| 58 | IRAK4 | 0.87437884 |
| 59 | ARAF | 0.87391074 |
| 60 | EIF2AK2 | 0.80945085 |
| 61 | MAP3K11 | 0.80676970 |
| 62 | IRAK3 | 0.78432633 |
| 63 | PIM1 | 0.76474937 |
| 64 | ATR | 0.76052415 |
| 65 | BLK | 0.75877867 |
| 66 | STK24 | 0.74758057 |
| 67 | ALK | 0.73445338 |
| 68 | CLK1 | 0.72107798 |
| 69 | CSNK2A1 | 0.70321989 |
| 70 | CSNK1G3 | 0.68974283 |
| 71 | TGFBR1 | 0.67746433 |
| 72 | MAP4K2 | 0.67637855 |
| 73 | ZAK | 0.67041087 |
| 74 | DYRK2 | 0.65477520 |
| 75 | PLK2 | 0.64771936 |
| 76 | BCR | 0.64577932 |
| 77 | MAPKAPK3 | 0.64443202 |
| 78 | TBK1 | 0.64091999 |
| 79 | CHEK1 | 0.63336205 |
| 80 | CSNK2A2 | 0.59095861 |
| 81 | MAP4K1 | 0.58603668 |
| 82 | KSR2 | 0.58279677 |
| 83 | CDK19 | 0.54818804 |
| 84 | CDK4 | 0.54200688 |
| 85 | PKN2 | 0.52950081 |
| 86 | CCNB1 | 0.50743181 |
| 87 | IKBKB | 0.47920191 |
| 88 | RIPK4 | 0.47832902 |
| 89 | CHEK2 | 0.47648935 |
| 90 | RPS6KA5 | 0.47552700 |
| 91 | TYK2 | 0.46442942 |
| 92 | CSNK1A1L | 0.46285383 |
| 93 | CDK14 | 0.45866887 |
| 94 | DAPK3 | 0.45770219 |
| 95 | CSNK1G1 | 0.45689618 |
| 96 | PASK | 0.45377088 |
| 97 | MAPKAPK2 | 0.45191339 |
| 98 | EPHA2 | 0.45001453 |
| 99 | CDK2 | 0.44845148 |
| 100 | BTK | 0.43924583 |
| 101 | TRIB3 | 0.42447753 |
| 102 | MAP3K2 | 0.40779586 |
| 103 | BRAF | 0.40741201 |
| 104 | BMPR1B | 0.38738205 |
| 105 | MAPKAPK5 | 0.37194359 |
| 106 | RPS6KA6 | 0.37052805 |
| 107 | RPS6KL1 | 0.35876039 |
| 108 | RPS6KC1 | 0.35876039 |
| 109 | MINK1 | 0.34764722 |
| 110 | PAK2 | 0.34198281 |
| 111 | CSNK1E | 0.34142165 |
| 112 | CDK18 | 0.33689079 |
| 113 | CDK11A | 0.33571810 |
| 114 | MAP2K3 | 0.33520292 |
| 115 | ERBB4 | 0.33009638 |
| 116 | MARK3 | 0.32867941 |
| 117 | KIT | 0.32572157 |
| 118 | LYN | 0.32315149 |
| 119 | PRKCI | 0.31284960 |
| 120 | CSNK1G2 | 0.30547008 |
| 121 | OBSCN | 0.30188088 |
| 122 | CDK15 | 0.29989600 |
| 123 | WNK4 | 0.29451113 |
| 124 | MYLK | 0.29068181 |
| 125 | JAK3 | 0.28505064 |
| 126 | AKT2 | 0.28487655 |
| 127 | TAOK2 | 0.28048023 |
| 128 | STK3 | 0.27663341 |
| 129 | ATM | 0.27480612 |
| 130 | CDK1 | 0.27431464 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Proteasome_Homo sapiens_hsa03050 | 5.34195678 |
| 2 | Ribosome_Homo sapiens_hsa03010 | 4.28719239 |
| 3 | DNA replication_Homo sapiens_hsa03030 | 4.13773402 |
| 4 | Mismatch repair_Homo sapiens_hsa03430 | 3.35010307 |
| 5 | RNA polymerase_Homo sapiens_hsa03020 | 3.26259912 |
| 6 | Spliceosome_Homo sapiens_hsa03040 | 2.97991150 |
| 7 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 2.86525195 |
| 8 | RNA transport_Homo sapiens_hsa03013 | 2.50153495 |
| 9 | Base excision repair_Homo sapiens_hsa03410 | 2.42552557 |
| 10 | Nucleotide excision repair_Homo sapiens_hsa03420 | 2.31014013 |
| 11 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 2.30869690 |
| 12 | Homologous recombination_Homo sapiens_hsa03440 | 2.23280719 |
| 13 | Cell cycle_Homo sapiens_hsa04110 | 2.07622596 |
| 14 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 2.05776596 |
| 15 | Parkinsons disease_Homo sapiens_hsa05012 | 2.00809419 |
| 16 | One carbon pool by folate_Homo sapiens_hsa00670 | 1.71797273 |
| 17 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.71231337 |
| 18 | Protein export_Homo sapiens_hsa03060 | 1.60994062 |
| 19 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.59423592 |
| 20 | Huntingtons disease_Homo sapiens_hsa05016 | 1.56427430 |
| 21 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 1.46584955 |
| 22 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.44195991 |
| 23 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 1.40291348 |
| 24 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 1.39786085 |
| 25 | RNA degradation_Homo sapiens_hsa03018 | 1.35270109 |
| 26 | Basal transcription factors_Homo sapiens_hsa03022 | 1.28309939 |
| 27 | Legionellosis_Homo sapiens_hsa05134 | 1.27573025 |
| 28 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 1.22067385 |
| 29 | p53 signaling pathway_Homo sapiens_hsa04115 | 1.13439452 |
| 30 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.12710600 |
| 31 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.12086559 |
| 32 | Alzheimers disease_Homo sapiens_hsa05010 | 1.11256138 |
| 33 | Non-homologous end-joining_Homo sapiens_hsa03450 | 1.10742320 |
| 34 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.10643941 |
| 35 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.06869268 |
| 36 | Shigellosis_Homo sapiens_hsa05131 | 1.04730688 |
| 37 | Purine metabolism_Homo sapiens_hsa00230 | 1.04616982 |
| 38 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 1.03101416 |
| 39 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 1.00553977 |
| 40 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.97545504 |
| 41 | Sulfur relay system_Homo sapiens_hsa04122 | 0.92282844 |
| 42 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.85288342 |
| 43 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.84830288 |
| 44 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.84798907 |
| 45 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.82663024 |
| 46 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.80567672 |
| 47 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.74259578 |
| 48 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.73496331 |
| 49 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.72086988 |
| 50 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.71656028 |
| 51 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.70740326 |
| 52 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.69332210 |
| 53 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.69155412 |
| 54 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.69132989 |
| 55 | Apoptosis_Homo sapiens_hsa04210 | 0.68390755 |
| 56 | Leishmaniasis_Homo sapiens_hsa05140 | 0.67777210 |
| 57 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.67681077 |
| 58 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.67297184 |
| 59 | Allograft rejection_Homo sapiens_hsa05330 | 0.66519976 |
| 60 | Carbon metabolism_Homo sapiens_hsa01200 | 0.64953499 |
| 61 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.64566959 |
| 62 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.64500111 |
| 63 | Thyroid cancer_Homo sapiens_hsa05216 | 0.64471853 |
| 64 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.64216159 |
| 65 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.63394787 |
| 66 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.63048495 |
| 67 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.61726555 |
| 68 | Phagosome_Homo sapiens_hsa04145 | 0.60684128 |
| 69 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.58784389 |
| 70 | Pertussis_Homo sapiens_hsa05133 | 0.58237784 |
| 71 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.57645913 |
| 72 | Measles_Homo sapiens_hsa05162 | 0.56888142 |
| 73 | Viral myocarditis_Homo sapiens_hsa05416 | 0.55312620 |
| 74 | HTLV-I infection_Homo sapiens_hsa05166 | 0.55256271 |
| 75 | * Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 0.54745087 |
| 76 | Salmonella infection_Homo sapiens_hsa05132 | 0.53602712 |
| 77 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.52612585 |
| 78 | Lysosome_Homo sapiens_hsa04142 | 0.51682625 |
| 79 | Asthma_Homo sapiens_hsa05310 | 0.51262658 |
| 80 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.50823362 |
| 81 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.50179997 |
| 82 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.49675849 |
| 83 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.48548261 |
| 84 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.47840967 |
| 85 | Tuberculosis_Homo sapiens_hsa05152 | 0.47669023 |
| 86 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.47529268 |
| 87 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.43676920 |
| 88 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.43266272 |
| 89 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.42821944 |
| 90 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.42765411 |
| 91 | Peroxisome_Homo sapiens_hsa04146 | 0.41376701 |
| 92 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.39979209 |
| 93 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.37722944 |
| 94 | Influenza A_Homo sapiens_hsa05164 | 0.37450560 |
| 95 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.37158689 |
| 96 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.35645961 |
| 97 | Hepatitis B_Homo sapiens_hsa05161 | 0.35114282 |
| 98 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.35037558 |
| 99 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.34963454 |
| 100 | Malaria_Homo sapiens_hsa05144 | 0.33975711 |
| 101 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.33826708 |
| 102 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.32685211 |
| 103 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.32580152 |
| 104 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.29577579 |
| 105 | Galactose metabolism_Homo sapiens_hsa00052 | 0.29408198 |
| 106 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.29310417 |
| 107 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.27831224 |
| 108 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.27076005 |
| 109 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.26981723 |
| 110 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.26336767 |
| 111 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.25329548 |
| 112 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.24708081 |
| 113 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.24005067 |
| 114 | Metabolic pathways_Homo sapiens_hsa01100 | 0.23471581 |
| 115 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.23309527 |
| 116 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.23060852 |
| 117 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.22478927 |
| 118 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.21699763 |
| 119 | Colorectal cancer_Homo sapiens_hsa05210 | 0.21216134 |
| 120 | Bladder cancer_Homo sapiens_hsa05219 | 0.21154313 |
| 121 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.21057515 |
| 122 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.20935935 |
| 123 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.19800697 |
| 124 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.18765674 |
| 125 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.16606272 |
| 126 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.13093007 |
| 127 | Mineral absorption_Homo sapiens_hsa04978 | 0.07802448 |
| 128 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.06924289 |
| 129 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.06116378 |
| 130 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.05894316 |
| 131 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.05641749 |
| 132 | Olfactory transduction_Homo sapiens_hsa04740 | 0.05065454 |
| 133 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.04261346 |
| 134 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 0.03153299 |
| 135 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.02067656 |
| 136 | Nitrogen metabolism_Homo sapiens_hsa00910 | -0.0055607 |
| 137 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | -0.0052848 |

